PharmTech Drug Digest 11.20
News|Articles|May 10, 2016

Colorcon to Open Film Coating Manufacturing Facility in Brazil

The new facility will produce GMP film coating productions for the pharmaceutical and nutritional markets in South America.

Colorcon announced on May 4, 2016 that it has invested in a new film coating manufacturing plant in Indaiatuba – São Paulo State, Brazil, the company said in a press announcement. Construction on the facility is scheduled for completion by October 2016 with the production of commercial scale product scheduled for January 2017, the company said. Colorcon wrote the new facility will produce GMP film coating productions for the pharmaceutical and nutritional markets in South America, including Argentina, Brazil, Chile, Paraguay, and Uruguay.

The new facility will aid in the formulation and development of pharmaceutical products through the company’s Technical Service Laboratory, which is already established in Cotia, São Paulo. The Cotia location was opened in 2000, and provides samples and applications support.

Source: Colorcon

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.